Nirmatrelvir-ritonavir is an effective and safe oral antiviral drug which have been shown to reduce the risk of progression to severe COVID-191 . It received emergency use authorization from the… Click to show full abstract
Nirmatrelvir-ritonavir is an effective and safe oral antiviral drug which have been shown to reduce the risk of progression to severe COVID-191 . It received emergency use authorization from the United States Food and Drug Administration (FDA) in December, 2021. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.